[PDF] Top 20 Update on the management of invasive bladder cancer 2012

... muscle-invasive bladder cancer may become candidates for neoadjuvant ...muscle-invasive bladder cancers, particularly those that are not deeply ...of bladder tumors with ... See full document

... In summary, while the use of collagenase is an emerging treatment for the management of DD, it is not curative and the long-term effects are still unknown. For the time being, surgical resection remains the ... See full document

... risk cancer undergoing radiation therapy or for men with large prostates and low-risk cancer anticipating brachytherapy; in an adjuvant setting for 2 to 3 years in men with high-risk prostate cancer ... See full document

... pain management and cutting down on this testing time is crucial to the widespread acceptance of this ...pain management, especially to move beyond studying dosing and toxicity to investigate the ef fi cacy ... See full document

... the management of pain, tricyclic antidepressants, selective serotonin noradrenaline reuptake inhibitors, and anticonvulsants alone or in combination are current first-line therapies followed by use of ... See full document

... in management of recalcitrant disease, resulting in quality-of-life improvement and assist- ing in aggressive medical ...surgical management in a multidis- ciplinary ... See full document

... One comparative retrospective study assessed the effect of invasive acne scar treatment and laser hair removal in a group of 55 patients on a combination of topical therapy a[r] ... See full document

... non-muscle-invasive bladder cancer (NMIBC) will fail intravesical bacillus Calmette-Guérin (BCG) ...T1 bladder cancer and/or carcinoma in situ (CIS or TIS) is more problematic, since ... See full document

... with NMIBC who received a radical cystectomy due to recur- rence of disease within 2 years from initial BCG therapy with outcome of patients who received radical surgery after 2 years; early radical cystectomy was ... See full document

... Another competitive muscarinic receptor antagonist, tolt- erodine, is metabolized in the liver by cytochrome P450 2D6 to its major pharmacologically active metabolite 5-hydroxymethyl tolterodine (5-HMT). Tolterodine IR ... See full document

... non-muscle-invasive bladder cancer ...on Cancer (AJCC) staging system, also known as the tumor node metastases (TNM) classification ...non-muscle-invasive bladder cancer ... See full document

... Danish Bladder Cancer Database (DaBlaCa-data) is to monitor the treatment of all patients diagnosed with invasive bladder cancer (BC) in ...from 2012 onward were included in the ... See full document

... TURBT is the first and gold standard treatment option for NMIBC. The quality of the initial TURBT is of utmost impor- tance. Complete resection of the tumour, including focal areas of suspected CIS and abnormal areas in ... See full document

... neoadjuvant MVAC was 77 months versus 46 months in those who underwent cystectomy alone (P = 0.06), with the cystec- tomy patients having a 33% higher risk of death than those receiving combination therapy (HR 1.33, 95% ... See full document

... Abstract: Transitional cell carcinoma (TCC) is the second most common urologic malignancy, and 70% of patients present with superficial or nonmuscle invasive bladder cancer (NMIBC). Intravesical ... See full document

... regarding management of muscle-invasive bladder cancer (MIBC) and metastatic BC in light of characteristics unique to the elderly population; describes what is known about health-related qual- ... See full document

... 20. Sternberg CN, de Mulder PH, Schornagel JH, et al. Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte ... See full document

... in invasive breast cancer compared with ductal carcinoma in situ, indicating that COL5A2 is related to tumor progression in breast ...cervical cancer, is highly correlated with poor prognosis in ... See full document

... severe urinary incontinence, nocturia, and proctitis causing bleeding. One patient had an aortoenteric fistula in the fourth part of the duodenum. However, being at the level of L3, this would not have been directly in ... See full document

... have revealed the prognostic value of various inflamma- tory factors such as albumin, C-reactive protein, Glasgow prognostic score, and prognostic index in cancer patients. The NLR represents an easily measured, ... See full document